Retour

Analysts Question Commercial Viability of Marinus' IV Ganaxolone After Interim Analysis Miss

News News

Monday, in an interim analysis of Marinus Pharmaceuticals Inc’s (NASDAQ:MRNS) phase 3 RAISE trial, evaluating intravenous (IV) ganaxolone as a treatment for refractory status epilepticus (RSE), failed to meet pre-defined “stopping criteria.” Marinus has completed RAISE enrollment at approximately 100 patients, with topline results expected in the summer of 2024. The company said the future development of IV ganaxolone in refractory status epilepticus will be assessed following a review of the final RAISE study results. An independent Data Monitoring Committee (DMC) recommended continuing the study. Cantor Fitzgerald said it shifted focus to oral ganaxolone (O-GNX), which is progressing in the global Phase 3 TrustTSC study for tuberous ...Full story available on Benzinga.com

Benzinga • 16/04/2024 à 20:45:12
Marinus Pharmaceuticals, Inc
Address: 5 RADNOR CORPORATE CENTER SUITE 500
Postal Code: 19087
City: RADNOR
State: PA
Phone Number: 484-801-4670
Website: https://www.marinuspharma.com
Status: Active
Company Info

Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.

List Date2014-07-31
MarketStocks
LocalUS
Primary ExchangeXNAS
TypeCS
Currency NameUSD
CIK0001267813
Composite figiBBG00253KMF6
Share Class figiBBG00253KMG5
Market Cap73,058,286 USD
SIC Code2834
SIC DescriptionPHARMACEUTICAL PREPARATIONS
Total Employees166
Share Class Shares Outstanding54930000
Weighted Shares Outstanding54931042
Round Lot100
Updated date2024-05-12
Stats
Last 5 days
15-05
14-05
13-05
10-05
9-05
Last
1.36
1.369
1.369
1.359
1.395
Variance
1.42%
0.07%
0.51%
-2.72%
-6.63%
Open
1.341
1.368
1.362
1.397
1.494
Highest
1.445
1.404
1.415
1.46
1.52
Lowest
1.435
1.395
1.415
1.446
1.517
History
PeriodVarhighestlowest
1 week
-9.97%
1.52
1.345
1 month
4.91%
1.635
1.345
3 month
-86.52%
10
1.345
6 month
-78.13%
6.23
1.345
1 year
-84.2%
8.62
1.345
3 year
-91.22%
15.56
1.345
5 year
-93.02%
20.4
1.345
10 year
-95.8%
32.64
1.345
Stock Financials
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-11 2023-08-10 2023-11-07 UNPUB
Assets 226,817,000 201,200,000 200,806,000 UNPUB
Current Assets 219,995,000 194,609,000 195,040,000 UNPUB
Current Liabilities 21,514,000 25,603,000 30,555,000 UNPUB
Equity 85,085,000 57,339,000 54,537,000 UNPUB
Equity Attributable To Noncontrolling Interest 0 0 0 UNPUB
Equity Attributable To Parent 85,085,000 57,339,000 54,537,000 UNPUB
Liabilities 141,732,000 143,861,000 146,269,000 UNPUB
Liabilities And Equity 226,817,000 201,200,000 200,806,000 UNPUB
Noncurrent Assets 6,822,000 6,591,000 5,766,000 UNPUB
Noncurrent Liabilities 120,218,000 118,258,000 115,714,000 UNPUB
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-11 2023-08-10 2023-11-07 UNPUB
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -93,647,000 -19,117,000 12,650,000 UNPUB
Net Cash Flow, Continuing -93,647,000 -19,117,000 12,650,000 UNPUB
Net Cash Flow From Financing Activities -174,000 237,000 25,903,000 UNPUB
Net Cash Flow From Financing Activities, Continuing -174,000 237,000 25,903,000 UNPUB
Net Cash Flow From Investing Activities -51,995,000 5,004,000 11,920,000 UNPUB
Net Cash Flow From Investing Activities, Continuing -51,995,000 5,004,000 11,920,000 UNPUB
Net Cash Flow From Operating Activities -41,478,000 -24,358,000 -25,173,000 UNPUB
Net Cash Flow From Operating Activities, Continuing -41,478,000 -24,358,000 -25,173,000 UNPUB
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-11 2023-08-10 2023-11-07 UNPUB
Comprehensive Income/Loss -34,656,000 -32,122,000 -32,929,000 UNPUB
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Comprehensive Income/Loss Attributable To Parent -34,656,000 -32,122,000 -32,929,000 UNPUB
Other Comprehensive Income/Loss 74,000 -32,122,000 -32,929,000 UNPUB
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-11 2023-08-10 2023-11-07 UNPUB
Basic Earnings Per Share -1 -1 -1 UNPUB
Benefits Costs and Expenses 45,110,000 39,553,000 40,310,000 UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses 43,343,000 37,520,000 38,984,000 UNPUB
Diluted Earnings Per Share -1 -1 -1 UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -34,730,000 -31,934,000 -32,972,000 UNPUB
Income/Loss From Continuing Operations Before Tax -34,730,000 -33,472,000 -32,972,000 UNPUB
Income Tax Expense/Benefit UNPUB -1,538,000 0 UNPUB
Interest Expense, Operating 4,147,000 4,208,000 4,242,000 UNPUB
Net Income/Loss -34,730,000 -31,934,000 -32,972,000 UNPUB
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Net Income/Loss Attributable To Parent -34,730,000 -31,934,000 -32,972,000 UNPUB
Net Income/Loss Available To Common Stockholders, Basic -34,730,000 -31,934,000 -32,972,000 UNPUB
Operating Expenses 43,343,000 37,520,000 38,984,000 UNPUB
Operating Income/Loss -32,963,000 -31,439,000 -31,646,000 UNPUB
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 UNPUB
Preferred Stock Dividends And Other Adjustments 0 0 0 UNPUB
Revenues 10,380,000 6,081,000 7,338,000 UNPUB
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-11 2022-11-07 2023-03-09
Assets 140,810,000 109,377,000 184,841,000 259,518,000
Current Assets 135,071,000 101,091,000 177,006,000 252,378,000
Current Liabilities 19,536,000 23,110,000 21,050,000 25,017,000
Equity 40,405,000 4,803,000 82,004,000 116,000,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 40,405,000 4,803,000 82,004,000 116,000,000
Liabilities 100,405,000 104,574,000 102,837,000 143,518,000
Liabilities And Equity 140,810,000 109,377,000 184,841,000 259,518,000
Noncurrent Assets 5,739,000 8,286,000 7,835,000 7,140,000
Noncurrent Liabilities 0 0 81,787,000 118,501,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-11 2022-11-07 2023-03-09
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow 3,392,000 -33,993,000 75,923,000 117,624,000
Net Cash Flow, Continuing 3,392,000 -33,993,000 75,923,000 117,624,000
Net Cash Flow From Financing Activities 31,133,000 14,000 -546,000 124,738,000
Net Cash Flow From Financing Activities, Continuing 31,133,000 14,000 -546,000 124,738,000
Net Cash Flow From Investing Activities -86,000 -335,000 106,114,000 105,772,000
Net Cash Flow From Investing Activities, Continuing -86,000 -335,000 106,114,000 105,772,000
Net Cash Flow From Operating Activities -27,655,000 -33,672,000 -29,645,000 -112,886,000
Net Cash Flow From Operating Activities, Continuing -27,655,000 -33,672,000 -29,645,000 -112,886,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-11 2022-11-07 2023-03-09
Comprehensive Income/Loss -19,361,000 -39,433,000 73,290,000 -19,816,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -19,361,000 -39,433,000 73,290,000 -19,816,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-12 2022-08-11 2022-11-07 2023-03-09
Basic Earnings Per Share -1 -1 2 -1
Benefits Costs and Expenses 33,547,000 38,556,000 -72,702,000 41,905,000
Cost Of Revenue 1,169,000 0 UNPUB UNPUB
Costs And Expenses 30,897,000 38,556,000 32,439,000 138,266,000
Diluted Earnings Per Share -1 -1 2 -1
Gross Profit 13,017,000 1,790,000 UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -19,361,000 -39,433,000 73,290,000 -19,816,000
Income/Loss From Continuing Operations Before Tax -19,361,000 -39,433,000 75,042,000 -16,427,000
Income Tax Expense/Benefit UNPUB UNPUB 1,752,000 3,389,000
Interest Expense, Operating 1,692,000 2,656,000 2,634,000 10,672,000
Net Income/Loss -19,361,000 -39,433,000 73,290,000 -19,816,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -19,361,000 -39,433,000 73,290,000 -19,816,000
Net Income/Loss Available To Common Stockholders, Basic -19,361,000 -39,433,000 71,634,000 -19,816,000
Operating Expenses 29,728,000 38,556,000 32,439,000 138,266,000
Operating Income/Loss -16,711,000 -36,766,000 -30,099,000 -112,788,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 1,656,000 0
Preferred Stock Dividends And Other Adjustments 0 0 1,656,000 0
Revenues 14,186,000 1,790,000 2,340,000 25,478,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-17 2021-08-10 2021-11-09 2022-03-24
Assets 133,859,000 124,989,000 158,873,000 136,840,000
Current Assets 129,798,000 120,924,000 153,491,000 131,678,000
Current Liabilities 16,121,000 16,694,000 37,676,000 40,566,000
Equity 115,334,000 95,059,000 78,494,000 53,486,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 115,334,000 95,059,000 78,494,000 53,486,000
Liabilities 18,525,000 29,930,000 80,379,000 83,354,000
Liabilities And Equity 133,859,000 124,989,000 158,873,000 136,840,000
Noncurrent Assets 4,061,000 4,065,000 5,382,000 5,162,000
Noncurrent Liabilities 0 0 42,703,000 42,788,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-17 2021-08-10 2021-11-09 2022-03-24
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -15,037,000 -10,979,000 32,608,000 -15,582,000
Net Cash Flow, Continuing -15,037,000 -10,979,000 32,608,000 -15,582,000
Net Cash Flow From Financing Activities 96,000 12,840,000 28,077,000 41,310,000
Net Cash Flow From Financing Activities, Continuing 96,000 12,840,000 28,077,000 41,310,000
Net Cash Flow From Investing Activities 1,042,000 -864,000 -872,000 -1,415,000
Net Cash Flow From Investing Activities, Continuing 1,042,000 -864,000 -872,000 -1,415,000
Net Cash Flow From Operating Activities -16,175,000 -22,955,000 5,403,000 -55,477,000
Net Cash Flow From Operating Activities, Continuing -16,175,000 -22,955,000 5,403,000 -55,477,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-17 2021-08-10 2021-11-09 2022-03-24
Comprehensive Income/Loss -27,141,000 -23,823,000 -19,507,000 -98,776,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -27,141,000 -23,823,000 -19,507,000 -98,776,000
Other Comprehensive Income/Loss 0 0 -19,507,000 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-17 2021-08-10 2021-11-09 2022-03-24
Basic Earnings Per Share UNPUB UNPUB -1 -3
Benefits Costs and Expenses UNPUB UNPUB 0 114,121,000
Cost Of Revenue UNPUB UNPUB 1,478,000 1,478,000
Costs And Expenses UNPUB UNPUB 29,283,000 112,276,000
Diluted Earnings Per Share UNPUB UNPUB -1 -3
Gross Profit UNPUB UNPUB 8,636,000 13,867,000
Income/Loss From Continuing Operations After Tax -27,141,000 -23,823,000 -19,507,000 -98,776,000
Income/Loss From Continuing Operations Before Tax -27,141,000 -23,823,000 10,114,000 -98,776,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating 0 351,000 678,000 2,582,000
Net Income/Loss -27,141,000 -23,823,000 -19,507,000 -98,776,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -27,141,000 -23,823,000 -19,507,000 -98,776,000
Net Income/Loss Available To Common Stockholders, Basic -27,141,000 -23,823,000 -19,507,000 -98,776,000
Operating Expenses UNPUB UNPUB 27,805,000 110,798,000
Operating Income/Loss -27,161,000 -23,485,000 -19,169,000 -96,931,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues UNPUB UNPUB 10,114,000 15,345,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-04 2020-08-06 2020-11-09 2021-03-09
Assets 84,558,000 113,443,000 99,526,000 150,462,000
Current Assets 79,998,000 109,035,000 95,172,000 146,267,000
Current Liabilities 10,325,000 9,503,000 9,439,000 10,729,000
Equity 43,112,000 101,145,000 87,423,000 137,199,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 43,112,000 101,145,000 87,423,000 137,199,000
Liabilities 13,245,000 12,298,000 12,103,000 13,263,000
Liabilities And Equity 84,558,000 113,443,000 99,526,000 150,462,000
Noncurrent Assets 4,560,000 4,408,000 4,354,000 4,195,000
Noncurrent Liabilities 0 0 2,664,000 2,534,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-04 2020-08-06 2020-11-09 2021-03-09
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -20,617,000 28,604,000 -11,593,000 47,566,000
Net Cash Flow, Continuing -20,617,000 28,604,000 -11,593,000 47,566,000
Net Cash Flow From Financing Activities 117,000 44,117,000 -106,000 109,216,000
Net Cash Flow From Financing Activities, Continuing 117,000 44,117,000 -106,000 109,216,000
Net Cash Flow From Investing Activities -6,697,000 495,000 2,982,000 -738,000
Net Cash Flow From Investing Activities, Continuing -6,697,000 495,000 2,982,000 -738,000
Net Cash Flow From Operating Activities -14,037,000 -16,008,000 -14,469,000 -60,912,000
Net Cash Flow From Operating Activities, Continuing -14,037,000 -16,008,000 -14,469,000 -60,912,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-04 2020-08-06 2020-11-09 2021-03-09
Comprehensive Income/Loss -18,672,000 -15,675,000 -15,674,000 -67,475,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -18,644,000 -15,675,000 -15,674,000 -67,475,000
Other Comprehensive Income/Loss 0 0 -15,674,000 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-04 2020-08-06 2020-11-09 2021-03-09
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -18,672,000 -15,675,000 -15,659,000 -67,475,000
Income/Loss From Continuing Operations Before Tax -18,672,000 -15,675,000 -15,659,000 -67,475,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -18,672,000 -15,675,000 -15,659,000 -67,475,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -18,672,000 -15,675,000 -15,659,000 -67,475,000
Net Income/Loss Available To Common Stockholders, Basic -27,552,000 -15,675,000 -15,659,000 -76,355,000
Operating Expenses UNPUB UNPUB UNPUB UNPUB
Operating Income/Loss -18,854,000 -15,882,000 -15,699,000 -67,937,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 8,880,000
Preferred Stock Dividends And Other Adjustments 0 0 0 8,880,000
Revenues UNPUB UNPUB UNPUB UNPUB
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-01 2019-08-08 2019-11-06 2020-03-16
Assets 67,619,000 58,965,000 45,800,000 98,842,000
Current Assets 62,872,000 54,193,000 41,141,000 94,134,000
Current Liabilities 6,677,000 9,204,000 8,571,000 8,031,000
Equity 57,745,000 46,585,000 34,071,000 59,569,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 57,745,000 46,585,000 34,071,000 59,569,000
Liabilities 9,874,000 12,380,000 11,729,000 11,073,000
Liabilities And Equity 67,619,000 58,965,000 45,800,000 98,842,000
Noncurrent Assets 4,747,000 4,772,000 4,659,000 4,708,000
Noncurrent Liabilities 0 0 3,158,000 3,042,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-01 2019-08-08 2019-11-06 2020-03-16
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -6,879,000 -11,412,000 -12,277,000 23,216,000
Net Cash Flow, Continuing -6,879,000 -11,412,000 -12,277,000 23,216,000
Net Cash Flow From Financing Activities -83,000 0 -18,000 67,968,000
Net Cash Flow From Financing Activities, Continuing -83,000 0 -18,000 67,968,000
Net Cash Flow From Investing Activities 4,868,000 -2,696,000 -255,000 3,881,000
Net Cash Flow From Investing Activities, Continuing 4,868,000 -2,696,000 -255,000 3,881,000
Net Cash Flow From Operating Activities -11,664,000 -8,716,000 -12,004,000 -48,633,000
Net Cash Flow From Operating Activities, Continuing -11,664,000 -8,716,000 -12,004,000 -48,633,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-01 2019-08-08 2019-11-06 2020-03-16
Comprehensive Income/Loss -12,483,000 -12,423,000 -13,806,000 -54,121,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -12,481,000 -12,423,000 -13,805,000 -54,121,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-01 2019-08-08 2019-11-06 2020-03-16
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -12,483,000 -12,423,000 -13,806,000 -54,121,000
Income/Loss From Continuing Operations Before Tax -12,483,000 -12,423,000 -13,806,000 -54,121,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -12,483,000 -12,423,000 -13,806,000 -54,121,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -12,483,000 -12,423,000 -13,806,000 -54,121,000
Net Income/Loss Available To Common Stockholders, Basic -12,483,000 -12,423,000 -13,806,000 -54,121,000
Operating Expenses UNPUB UNPUB UNPUB UNPUB
Operating Income/Loss -12,539,000 -12,512,000 -13,899,000 -54,422,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues UNPUB UNPUB UNPUB UNPUB
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-02 2018-08-03 2018-10-29 2019-03-12
Assets 55,033,000 48,687,000 42,099,000 75,234,000
Current Assets 53,718,000 47,407,000 40,817,000 73,940,000
Current Liabilities 1,794,000 3,560,000 6,877,000 6,909,000
Equity 53,125,000 45,020,000 35,122,000 68,325,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 53,125,000 45,020,000 35,122,000 68,325,000
Liabilities 1,908,000 3,667,000 6,977,000 6,909,000
Liabilities And Equity 55,033,000 48,687,000 42,099,000 75,234,000
Noncurrent Assets 1,315,000 1,280,000 1,282,000 1,294,000
Noncurrent Liabilities 114,000 107,000 100,000 0
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-02 2018-08-03 2018-10-29 2019-03-12
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -6,350,000 -5,714,000 -1,805,000 34,196,000
Net Cash Flow, Continuing -6,350,000 -5,714,000 -1,805,000 34,196,000
Net Cash Flow From Financing Activities -193,000 14,000 0 42,121,000
Net Cash Flow From Financing Activities, Continuing -193,000 14,000 0 42,121,000
Net Cash Flow From Investing Activities -8,000 0 5,002,000 19,917,000
Net Cash Flow From Investing Activities, Continuing -8,000 0 5,002,000 19,917,000
Net Cash Flow From Operating Activities -6,149,000 -5,728,000 -6,807,000 -27,842,000
Net Cash Flow From Operating Activities, Continuing -6,149,000 -5,728,000 -6,807,000 -27,842,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-02 2018-08-03 2018-10-29 2019-03-12
Comprehensive Income/Loss -5,999,000 -9,504,000 -11,110,000 -36,632,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -6,010,000 -9,466,000 -11,068,000 -36,632,000
Other Comprehensive Income/Loss 0 0 0 94,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-02 2018-08-03 2018-10-29 2019-03-12
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -5,999,000 -9,504,000 -11,110,000 -36,726,000
Income/Loss From Continuing Operations Before Tax -5,999,000 -9,504,000 -11,110,000 -36,726,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss -5,999,000 -9,504,000 -11,110,000 -36,726,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -5,999,000 -9,504,000 -11,110,000 -36,726,000
Net Income/Loss Available To Common Stockholders, Basic -5,999,000 -9,504,000 -11,110,000 -36,726,000
Operating Expenses UNPUB UNPUB UNPUB UNPUB
Operating Income/Loss -6,114,000 -9,570,000 -11,221,000 -37,179,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues UNPUB UNPUB UNPUB UNPUB
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-01 2017-08-01 2017-10-31 2018-03-07
Assets 26,824,000 22,095,000 64,657,000 60,672,000
Current Assets 25,676,000 20,959,000 43,547,000 54,370,000
Current Liabilities 6,569,000 5,674,000 2,430,000 2,544,000
Equity 19,248,000 16,289,000 62,100,000 58,008,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 19,248,000 16,289,000 62,100,000 58,008,000
Liabilities 7,576,000 5,806,000 2,557,000 2,664,000
Liabilities And Equity 26,824,000 22,095,000 64,657,000 60,672,000
Noncurrent Assets 1,148,000 1,136,000 21,110,000 6,302,000
Noncurrent Liabilities 1,007,000 132,000 127,000 120,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-01 2017-08-01 2017-10-31 2018-03-07
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -3,602,000 -3,045,000 17,999,000 7,353,000
Net Cash Flow, Continuing -3,602,000 -3,045,000 17,999,000 7,353,000
Net Cash Flow From Financing Activities 1,635,000 -104,000 45,815,000 47,589,000
Net Cash Flow From Financing Activities, Continuing 1,635,000 -104,000 45,815,000 47,589,000
Net Cash Flow From Investing Activities 1,612,000 1,423,000 -24,693,000 -21,420,000
Net Cash Flow From Investing Activities, Continuing 1,612,000 1,423,000 -24,693,000 -21,420,000
Net Cash Flow From Operating Activities -6,849,000 -4,364,000 -3,123,000 -18,816,000
Net Cash Flow From Operating Activities, Continuing -6,849,000 -4,364,000 -3,123,000 -18,816,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-01 2017-08-01 2017-10-31 2018-03-07
Comprehensive Income/Loss -5,438,000 -4,552,000 -4,170,000 -18,994,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -5,438,000 -4,552,000 -4,188,000 -18,994,000
Other Comprehensive Income/Loss 0 0 0 -96,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-01 2017-08-01 2017-10-31 2018-03-07
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -5,438,000 -4,552,000 -4,170,000 -18,898,000
Income/Loss From Continuing Operations Before Tax -5,438,000 -4,552,000 -4,170,000 -18,898,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating 84,000 72,000 3,000 159,000
Net Income/Loss -5,438,000 -4,552,000 -4,170,000 -18,898,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -5,438,000 -4,552,000 -4,170,000 -18,898,000
Net Income/Loss Available To Common Stockholders, Basic -5,438,000 -4,552,000 -4,170,000 -18,898,000
Operating Expenses UNPUB UNPUB UNPUB UNPUB
Operating Income/Loss -5,385,000 -4,508,000 -4,213,000 -19,043,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues UNPUB UNPUB UNPUB UNPUB
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-02 2016-08-09 2016-11-08 2017-03-13
Assets 52,786,000 46,165,000 38,635,000 31,447,000
Current Assets 51,716,000 44,404,000 37,123,000 30,299,000
Current Liabilities 7,754,000 10,196,000 9,181,000 8,084,000
Equity 40,567,000 32,331,000 26,693,000 21,479,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 40,567,000 32,331,000 26,693,000 21,479,000
Liabilities 12,219,000 13,834,000 11,942,000 9,968,000
Liabilities And Equity 52,786,000 46,165,000 38,635,000 31,447,000
Noncurrent Assets 1,070,000 1,761,000 1,512,000 1,148,000
Noncurrent Liabilities 4,465,000 3,638,000 2,761,000 1,884,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-02 2016-08-09 2016-11-08 2017-03-13
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -4,993,000 -7,627,000 -6,207,000 -25,544,000
Net Cash Flow, Continuing -4,993,000 -7,627,000 -6,207,000 -25,544,000
Net Cash Flow From Financing Activities -101,000 -152,000 -1,001,000 -2,171,000
Net Cash Flow From Financing Activities, Continuing -101,000 -152,000 -1,001,000 -2,171,000
Net Cash Flow From Investing Activities 1,190,000 -1,295,000 1,253,000 1,396,000
Net Cash Flow From Investing Activities, Continuing 1,190,000 -1,295,000 1,253,000 1,396,000
Net Cash Flow From Operating Activities -6,082,000 -6,180,000 -6,459,000 -24,769,000
Net Cash Flow From Operating Activities, Continuing -6,082,000 -6,180,000 -6,459,000 -24,769,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-02 2016-08-09 2016-11-08 2017-03-13
Comprehensive Income/Loss -7,216,000 -8,949,000 -6,464,000 -28,643,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -7,216,000 -8,949,000 -6,464,000 -28,643,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-02 2016-08-09 2016-11-08 2017-03-13
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -7,216,000 -8,949,000 -6,464,000 -28,643,000
Income/Loss From Continuing Operations Before Tax -7,216,000 -8,949,000 -6,464,000 -28,643,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating 124,000 124,000 118,000 464,000
Net Income/Loss -7,216,000 -8,949,000 -6,464,000 -28,643,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -7,216,000 -8,949,000 -6,464,000 -28,643,000
Net Income/Loss Available To Common Stockholders, Basic -7,216,000 -8,949,000 -6,464,000 -28,643,000
Operating Expenses UNPUB UNPUB UNPUB UNPUB
Operating Income/Loss -7,098,000 -8,844,000 -6,369,000 -28,242,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues UNPUB UNPUB UNPUB 0
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-14 2015-08-04 2015-10-29 2016-03-07
Assets 46,351,000 41,040,000 36,753,000 59,662,000
Current Assets 45,794,000 40,135,000 34,860,000 57,767,000
Current Liabilities 5,446,000 5,847,000 6,663,000 7,435,000
Equity 34,730,000 29,884,000 25,658,000 46,921,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 34,730,000 29,884,000 25,658,000 46,921,000
Liabilities 11,621,000 11,156,000 11,095,000 12,741,000
Liabilities And Equity 46,351,000 41,040,000 36,753,000 59,662,000
Noncurrent Assets 557,000 905,000 1,893,000 1,895,000
Noncurrent Liabilities 6,175,000 5,309,000 4,432,000 5,306,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-14 2015-08-04 2015-10-29 2016-03-07
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow -5,243,000 -5,544,000 -10,906,000 2,002,000
Net Cash Flow, Continuing -5,243,000 -5,544,000 -10,906,000 2,002,000
Net Cash Flow From Financing Activities 200,000 34,000 -32,000 28,445,000
Net Cash Flow From Financing Activities, Continuing 200,000 34,000 -32,000 28,445,000
Net Cash Flow From Investing Activities -1,491,000 -352,000 -4,972,000 -6,314,000
Net Cash Flow From Investing Activities, Continuing -1,491,000 -352,000 -4,972,000 -6,314,000
Net Cash Flow From Operating Activities -3,952,000 -5,226,000 -5,902,000 -20,129,000
Net Cash Flow From Operating Activities, Continuing -3,952,000 -5,226,000 -5,902,000 -20,129,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-14 2015-08-04 2015-10-29 2016-03-07
Comprehensive Income/Loss -7,007,000 -5,273,000 -4,963,000 -24,850,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent -7,007,000 -5,273,000 -4,963,000 -24,850,000
Other Comprehensive Income/Loss 0 0 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-14 2015-08-04 2015-10-29 2016-03-07
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax -7,007,000 -5,273,000 -4,963,000 -24,850,000
Income/Loss From Continuing Operations Before Tax -7,007,000 -5,273,000 -4,963,000 -24,850,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating 116,000 117,000 121,000 475,000
Net Income/Loss -7,007,000 -5,273,000 -4,963,000 -24,850,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent -7,007,000 -5,273,000 -4,963,000 -24,850,000
Net Income/Loss Available To Common Stockholders, Basic -7,007,000 -5,273,000 -4,963,000 -24,850,000
Operating Expenses UNPUB UNPUB UNPUB UNPUB
Operating Income/Loss -6,915,000 -5,170,000 -4,850,000 -24,432,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues UNPUB UNPUB UNPUB 0
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB 2014-11-13 2015-03-12
Assets UNPUB UNPUB 47,560,878 50,213,000
Current Assets UNPUB UNPUB 47,544,235 50,148,000
Current Liabilities UNPUB UNPUB 1,335,386 2,039,000
Equity UNPUB UNPUB 44,225,492 41,154,000
Equity Attributable To Noncontrolling Interest UNPUB UNPUB 0 0
Equity Attributable To Parent UNPUB UNPUB 44,225,492 41,154,000
Liabilities UNPUB UNPUB 3,335,386 9,059,000
Liabilities And Equity UNPUB UNPUB 47,560,878 50,213,000
Noncurrent Assets UNPUB UNPUB 16,643 65,000
Noncurrent Liabilities UNPUB UNPUB 2,000,000 7,020,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB 2014-11-13 2015-03-12
Exchange Gains/Losses UNPUB UNPUB UNPUB UNPUB
Net Cash Flow UNPUB UNPUB UNPUB 39,683,000
Net Cash Flow, Continuing UNPUB UNPUB UNPUB 39,683,000
Net Cash Flow From Financing Activities UNPUB UNPUB UNPUB 48,305,000
Net Cash Flow From Financing Activities, Continuing UNPUB UNPUB UNPUB 48,305,000
Net Cash Flow From Investing Activities UNPUB UNPUB UNPUB -33,000
Net Cash Flow From Investing Activities, Continuing UNPUB UNPUB UNPUB -33,000
Net Cash Flow From Operating Activities UNPUB UNPUB UNPUB -8,589,000
Net Cash Flow From Operating Activities, Continuing UNPUB UNPUB UNPUB -8,589,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB 2014-11-13 2015-03-12
Comprehensive Income/Loss UNPUB UNPUB -1,668,000 -10,833,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB 0 0
Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB -1,668,000 -10,833,000
Other Comprehensive Income/Loss UNPUB UNPUB 0 0
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB 2014-11-13 2015-03-12
Basic Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Benefits Costs and Expenses UNPUB UNPUB UNPUB UNPUB
Cost Of Revenue UNPUB UNPUB UNPUB UNPUB
Costs And Expenses UNPUB UNPUB UNPUB UNPUB
Diluted Earnings Per Share UNPUB UNPUB UNPUB UNPUB
Gross Profit UNPUB UNPUB UNPUB UNPUB
Income/Loss From Continuing Operations After Tax UNPUB UNPUB -1,668,000 -10,833,000
Income/Loss From Continuing Operations Before Tax UNPUB UNPUB -1,668,000 -10,833,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB UNPUB
Interest Expense, Operating UNPUB UNPUB 29,461 117,000
Net Income/Loss UNPUB UNPUB -1,668,000 -10,833,000
Net Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB 0 0
Net Income/Loss Attributable To Parent UNPUB UNPUB -1,668,000 -10,833,000
Net Income/Loss Available To Common Stockholders, Basic UNPUB UNPUB -2,040,000 -13,378,000
Operating Expenses UNPUB UNPUB UNPUB UNPUB
Operating Income/Loss UNPUB UNPUB -2,437,041 -11,920,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic UNPUB UNPUB 372,000 2,545,000
Preferred Stock Dividends And Other Adjustments UNPUB UNPUB 372,000 2,545,000
Revenues UNPUB UNPUB UNPUB UNPUB
Calendar
16 May 2024 (Time UTC) Actual Previous Consensus
08:30
United States
MAY 10
215000.000
★★
08:30
United States
MAY 10
231000.000
220000.000
★★
08:30
United States
APR
0.400
0.400
08:30
United States
APR
0.400
08:30
United States
APR
1321000.000
1410000.000
★★
08:30
United States
APR
-14.700
08:30
United States
APR
-1.400
08:30
United States
MAY 10
1785000.000
1780000.000
★★
08:30
United States
MAY
-10.700
08:30
United States
MAY
20.000
08:30
United States
MAY
12.200
08:30
United States
MAY
34.300
08:30
United States
MAY
23.000
★★★
08:30
United States
MAY
15.500
7.700
★★
08:30
United States
MAY
Options
Ticker
CFI
Contract Type
Exercise Style
Share Per Contract
Strike Price
Primary Exchange
Expiration Date
O:MRNS240419P00020000 OPASPS Put American 100 20 BATO 2024-04-19
O:MRNS240419P00016000 OPASPS Put American 100 16 BATO 2024-04-19
O:MRNS240419P00014000 OPASPS Put American 100 14 BATO 2024-04-19
O:MRNS240419C00020000 OCASPS Call American 100 20 BATO 2024-04-19
O:MRNS240419C00016000 OCASPS Call American 100 16 BATO 2024-04-19
O:MRNS240419C00014000 OCASPS Call American 100 14 BATO 2024-04-19
O:MRNS240419P00015000 OPASPS Put American 100 15 BATO 2024-04-19
O:MRNS240419P00013000 OPASPS Put American 100 13 BATO 2024-04-19
O:MRNS240419P00012000 OPASPS Put American 100 12 BATO 2024-04-19
O:MRNS240419C00015000 OCASPS Call American 100 15 BATO 2024-04-19
O:MRNS240419P00011000 OPASPS Put American 100 11 BATO 2024-04-19
O:MRNS240419P00010000 OPASPS Put American 100 10 BATO 2024-04-19
O:MRNS240419P00009000 OPASPS Put American 100 9 BATO 2024-04-19
O:MRNS240419P00008000 OPASPS Put American 100 8 BATO 2024-04-19
O:MRNS240419P00007000 OPASPS Put American 100 7 BATO 2024-04-19
O:MRNS240419P00006000 OPASPS Put American 100 6 BATO 2024-04-19
O:MRNS240419P00005000 OPASPS Put American 100 5 BATO 2024-04-19
O:MRNS240419P00004000 OPASPS Put American 100 4 BATO 2024-04-19
O:MRNS240419P00003000 OPASPS Put American 100 3 BATO 2024-04-19
O:MRNS240419P00002000 OPASPS Put American 100 2 BATO 2024-04-19
O:MRNS240419P00001000 OPASPS Put American 100 1 BATO 2024-04-19
O:MRNS240419C00013000 OCASPS Call American 100 13 BATO 2024-04-19
O:MRNS240419C00012000 OCASPS Call American 100 12 BATO 2024-04-19
O:MRNS240419C00011000 OCASPS Call American 100 11 BATO 2024-04-19
O:MRNS240419C00010000 OCASPS Call American 100 10 BATO 2024-04-19
O:MRNS240419C00009000 OCASPS Call American 100 9 BATO 2024-04-19
O:MRNS240419C00008000 OCASPS Call American 100 8 BATO 2024-04-19
O:MRNS240419C00007000 OCASPS Call American 100 7 BATO 2024-04-19
O:MRNS240419C00006000 OCASPS Call American 100 6 BATO 2024-04-19
O:MRNS240419C00005000 OCASPS Call American 100 5 BATO 2024-04-19
O:MRNS240419C00004000 OCASPS Call American 100 4 BATO 2024-04-19
O:MRNS240419C00003000 OCASPS Call American 100 3 BATO 2024-04-19
O:MRNS240419C00002000 OCASPS Call American 100 2 BATO 2024-04-19
O:MRNS240419C00001000 OCASPS Call American 100 1 BATO 2024-04-19
O:MRNS240315P00017000 OPASPS Put American 100 17 BATO 2024-03-15
O:MRNS240315P00016000 OPASPS Put American 100 16 BATO 2024-03-15
O:MRNS240315P00015000 OPASPS Put American 100 15 BATO 2024-03-15
O:MRNS240315P00014000 OPASPS Put American 100 14 BATO 2024-03-15
O:MRNS240315P00013000 OPASPS Put American 100 13 BATO 2024-03-15
O:MRNS240315P00012000 OPASPS Put American 100 12 BATO 2024-03-15
O:MRNS240315P00011000 OPASPS Put American 100 11 BATO 2024-03-15
O:MRNS240315P00010000 OPASPS Put American 100 10 BATO 2024-03-15
O:MRNS240315P00009000 OPASPS Put American 100 9 BATO 2024-03-15
O:MRNS240315P00008000 OPASPS Put American 100 8 BATO 2024-03-15
O:MRNS240315P00007000 OPASPS Put American 100 7 BATO 2024-03-15
O:MRNS240315P00006000 OPASPS Put American 100 6 BATO 2024-03-15
O:MRNS240315P00005000 OPASPS Put American 100 5 BATO 2024-03-15
O:MRNS240315P00004000 OPASPS Put American 100 4 BATO 2024-03-15
O:MRNS240315P00003000 OPASPS Put American 100 3 BATO 2024-03-15
O:MRNS240315P00002000 OPASPS Put American 100 2 BATO 2024-03-15
O:MRNS240315P00001000 OPASPS Put American 100 1 BATO 2024-03-15
O:MRNS240315C00017000 OCASPS Call American 100 17 BATO 2024-03-15
O:MRNS240315C00016000 OCASPS Call American 100 16 BATO 2024-03-15
O:MRNS240315C00015000 OCASPS Call American 100 15 BATO 2024-03-15
O:MRNS240315C00014000 OCASPS Call American 100 14 BATO 2024-03-15
O:MRNS240315C00013000 OCASPS Call American 100 13 BATO 2024-03-15
O:MRNS240315C00012000 OCASPS Call American 100 12 BATO 2024-03-15
O:MRNS240315C00011000 OCASPS Call American 100 11 BATO 2024-03-15
O:MRNS240315C00010000 OCASPS Call American 100 10 BATO 2024-03-15
O:MRNS240315C00009000 OCASPS Call American 100 9 BATO 2024-03-15
O:MRNS240315C00008000 OCASPS Call American 100 8 BATO 2024-03-15
O:MRNS240315C00007000 OCASPS Call American 100 7 BATO 2024-03-15
O:MRNS240315C00006000 OCASPS Call American 100 6 BATO 2024-03-15
O:MRNS240315C00005000 OCASPS Call American 100 5 BATO 2024-03-15
O:MRNS240315C00004000 OCASPS Call American 100 4 BATO 2024-03-15
O:MRNS240315C00003000 OCASPS Call American 100 3 BATO 2024-03-15
O:MRNS240315C00002000 OCASPS Call American 100 2 BATO 2024-03-15
O:MRNS240315C00001000 OCASPS Call American 100 1 BATO 2024-03-15
O:MRNS240216C00004000 OCASPS Call American 100 4 BATO 2024-02-16
O:MRNS240216C00003000 OCASPS Call American 100 3 BATO 2024-02-16
O:MRNS240216C00002000 OCASPS Call American 100 2 BATO 2024-02-16
O:MRNS240216C00001000 OCASPS Call American 100 1 BATO 2024-02-16
O:MRNS240216P00020000 OPASPS Put American 100 20 BATO 2024-02-16
O:MRNS240216C00020000 OCASPS Call American 100 20 BATO 2024-02-16
O:MRNS240216P00017000 OPASPS Put American 100 17 BATO 2024-02-16
O:MRNS240216P00016000 OPASPS Put American 100 16 BATO 2024-02-16
O:MRNS240216P00015000 OPASPS Put American 100 15 BATO 2024-02-16
O:MRNS240216P00014000 OPASPS Put American 100 14 BATO 2024-02-16
O:MRNS240216P00013000 OPASPS Put American 100 13 BATO 2024-02-16
O:MRNS240216P00012000 OPASPS Put American 100 12 BATO 2024-02-16
O:MRNS240216P00011000 OPASPS Put American 100 11 BATO 2024-02-16
O:MRNS240216P00010000 OPASPS Put American 100 10 BATO 2024-02-16
O:MRNS240216P00009000 OPASPS Put American 100 9 BATO 2024-02-16
O:MRNS240216P00008000 OPASPS Put American 100 8 BATO 2024-02-16
O:MRNS240216P00007000 OPASPS Put American 100 7 BATO 2024-02-16
O:MRNS240216P00006000 OPASPS Put American 100 6 BATO 2024-02-16
O:MRNS240216P00005000 OPASPS Put American 100 5 BATO 2024-02-16
O:MRNS240216P00004000 OPASPS Put American 100 4 BATO 2024-02-16
O:MRNS240216P00003000 OPASPS Put American 100 3 BATO 2024-02-16
O:MRNS240216P00002000 OPASPS Put American 100 2 BATO 2024-02-16
O:MRNS240216P00001000 OPASPS Put American 100 1 BATO 2024-02-16
O:MRNS240216C00017000 OCASPS Call American 100 17 BATO 2024-02-16
O:MRNS240216C00016000 OCASPS Call American 100 16 BATO 2024-02-16
O:MRNS240216C00015000 OCASPS Call American 100 15 BATO 2024-02-16
O:MRNS240216C00014000 OCASPS Call American 100 14 BATO 2024-02-16
O:MRNS240216C00013000 OCASPS Call American 100 13 BATO 2024-02-16
O:MRNS240216C00012000 OCASPS Call American 100 12 BATO 2024-02-16
O:MRNS240216C00011000 OCASPS Call American 100 11 BATO 2024-02-16
O:MRNS240216C00010000 OCASPS Call American 100 10 BATO 2024-02-16
O:MRNS240216C00009000 OCASPS Call American 100 9 BATO 2024-02-16
O:MRNS240216C00008000 OCASPS Call American 100 8 BATO 2024-02-16
O:MRNS240216C00007000 OCASPS Call American 100 7 BATO 2024-02-16
O:MRNS240216C00006000 OCASPS Call American 100 6 BATO 2024-02-16
O:MRNS240216C00005000 OCASPS Call American 100 5 BATO 2024-02-16
O:MRNS240119P00020000 OPASPS Put American 100 20 BATO 2024-01-19
O:MRNS240119P00017000 OPASPS Put American 100 17 BATO 2024-01-19
O:MRNS240119P00016000 OPASPS Put American 100 16 BATO 2024-01-19
O:MRNS240119P00015000 OPASPS Put American 100 15 BATO 2024-01-19
O:MRNS240119P00014000 OPASPS Put American 100 14 BATO 2024-01-19
O:MRNS240119P00013000 OPASPS Put American 100 13 BATO 2024-01-19
O:MRNS240119P00012000 OPASPS Put American 100 12 BATO 2024-01-19
O:MRNS240119P00011000 OPASPS Put American 100 11 BATO 2024-01-19
O:MRNS240119P00010000 OPASPS Put American 100 10 BATO 2024-01-19
O:MRNS240119P00009000 OPASPS Put American 100 9 BATO 2024-01-19
O:MRNS240119P00008000 OPASPS Put American 100 8 BATO 2024-01-19
O:MRNS240119P00007000 OPASPS Put American 100 7 BATO 2024-01-19
O:MRNS240119P00006000 OPASPS Put American 100 6 BATO 2024-01-19
O:MRNS240119P00005000 OPASPS Put American 100 5 BATO 2024-01-19
O:MRNS240119P00004000 OPASPS Put American 100 4 BATO 2024-01-19
O:MRNS240119P00003000 OPASPS Put American 100 3 BATO 2024-01-19
O:MRNS240119P00002000 OPASPS Put American 100 2 BATO 2024-01-19
O:MRNS240119P00001000 OPASPS Put American 100 1 BATO 2024-01-19
O:MRNS240119C00020000 OCASPS Call American 100 20 BATO 2024-01-19
O:MRNS240119C00017000 OCASPS Call American 100 17 BATO 2024-01-19
O:MRNS240119C00016000 OCASPS Call American 100 16 BATO 2024-01-19
O:MRNS240119C00015000 OCASPS Call American 100 15 BATO 2024-01-19
O:MRNS240119C00014000 OCASPS Call American 100 14 BATO 2024-01-19
O:MRNS240119C00013000 OCASPS Call American 100 13 BATO 2024-01-19
O:MRNS240119C00012000 OCASPS Call American 100 12 BATO 2024-01-19
O:MRNS240119C00011000 OCASPS Call American 100 11 BATO 2024-01-19
O:MRNS240119C00010000 OCASPS Call American 100 10 BATO 2024-01-19
O:MRNS240119C00009000 OCASPS Call American 100 9 BATO 2024-01-19
O:MRNS240119C00008000 OCASPS Call American 100 8 BATO 2024-01-19
O:MRNS240119C00007000 OCASPS Call American 100 7 BATO 2024-01-19
O:MRNS240119C00006000 OCASPS Call American 100 6 BATO 2024-01-19
O:MRNS240119C00005000 OCASPS Call American 100 5 BATO 2024-01-19
O:MRNS240119C00004000 OCASPS Call American 100 4 BATO 2024-01-19
O:MRNS240119C00003000 OCASPS Call American 100 3 BATO 2024-01-19
O:MRNS240119C00002000 OCASPS Call American 100 2 BATO 2024-01-19
O:MRNS240119C00001000 OCASPS Call American 100 1 BATO 2024-01-19
O:MRNS240119P00021000 OPASPS Put American 100 21 BATO 2024-01-19
O:MRNS240119P00019000 OPASPS Put American 100 19 BATO 2024-01-19
O:MRNS240119P00018000 OPASPS Put American 100 18 BATO 2024-01-19
O:MRNS240119C00021000 OCASPS Call American 100 21 BATO 2024-01-19
O:MRNS240119C00019000 OCASPS Call American 100 19 BATO 2024-01-19
O:MRNS240119C00018000 OCASPS Call American 100 18 BATO 2024-01-19
O:MRNS231215P00014000 OPASPS Put American 100 14 BATO 2023-12-15
O:MRNS231215P00013000 OPASPS Put American 100 13 BATO 2023-12-15
O:MRNS231215P00012000 OPASPS Put American 100 12 BATO 2023-12-15
O:MRNS231215P00011000 OPASPS Put American 100 11 BATO 2023-12-15
O:MRNS231215P00010000 OPASPS Put American 100 10 BATO 2023-12-15
O:MRNS231215P00009000 OPASPS Put American 100 9 BATO 2023-12-15
O:MRNS231215P00008000 OPASPS Put American 100 8 BATO 2023-12-15
O:MRNS231215P00007000 OPASPS Put American 100 7 BATO 2023-12-15
O:MRNS231215P00006000 OPASPS Put American 100 6 BATO 2023-12-15
O:MRNS231215P00005000 OPASPS Put American 100 5 BATO 2023-12-15
O:MRNS231215P00004000 OPASPS Put American 100 4 BATO 2023-12-15
O:MRNS231215P00003000 OPASPS Put American 100 3 BATO 2023-12-15
O:MRNS231215P00002000 OPASPS Put American 100 2 BATO 2023-12-15
O:MRNS231215P00001000 OPASPS Put American 100 1 BATO 2023-12-15
O:MRNS231215C00014000 OCASPS Call American 100 14 BATO 2023-12-15
O:MRNS231215C00013000 OCASPS Call American 100 13 BATO 2023-12-15
O:MRNS231215C00012000 OCASPS Call American 100 12 BATO 2023-12-15
O:MRNS231215C00011000 OCASPS Call American 100 11 BATO 2023-12-15
O:MRNS231215C00010000 OCASPS Call American 100 10 BATO 2023-12-15
O:MRNS231215C00009000 OCASPS Call American 100 9 BATO 2023-12-15
O:MRNS231215C00008000 OCASPS Call American 100 8 BATO 2023-12-15
O:MRNS231215C00007000 OCASPS Call American 100 7 BATO 2023-12-15
O:MRNS231215C00006000 OCASPS Call American 100 6 BATO 2023-12-15
O:MRNS231215C00005000 OCASPS Call American 100 5 BATO 2023-12-15
O:MRNS231215C00004000 OCASPS Call American 100 4 BATO 2023-12-15
O:MRNS231215C00003000 OCASPS Call American 100 3 BATO 2023-12-15
O:MRNS231215C00002000 OCASPS Call American 100 2 BATO 2023-12-15
O:MRNS231215C00001000 OCASPS Call American 100 1 BATO 2023-12-15
O:MRNS231117P00015000 OPASPS Put American 100 15 BATO 2023-11-17
O:MRNS231117P00014000 OPASPS Put American 100 14 BATO 2023-11-17
O:MRNS231117P00013000 OPASPS Put American 100 13 BATO 2023-11-17
O:MRNS231117P00012000 OPASPS Put American 100 12 BATO 2023-11-17
O:MRNS231117P00011000 OPASPS Put American 100 11 BATO 2023-11-17
O:MRNS231117P00010000 OPASPS Put American 100 10 BATO 2023-11-17
O:MRNS231117P00009000 OPASPS Put American 100 9 BATO 2023-11-17
O:MRNS231117P00008000 OPASPS Put American 100 8 BATO 2023-11-17
O:MRNS231117P00007000 OPASPS Put American 100 7 BATO 2023-11-17
O:MRNS231117P00006000 OPASPS Put American 100 6 BATO 2023-11-17
O:MRNS231117P00005000 OPASPS Put American 100 5 BATO 2023-11-17
O:MRNS231117P00004000 OPASPS Put American 100 4 BATO 2023-11-17
O:MRNS231117P00003000 OPASPS Put American 100 3 BATO 2023-11-17
O:MRNS231117P00002000 OPASPS Put American 100 2 BATO 2023-11-17
O:MRNS231117P00001000 OPASPS Put American 100 1 BATO 2023-11-17
O:MRNS231117C00015000 OCASPS Call American 100 15 BATO 2023-11-17
O:MRNS231117C00014000 OCASPS Call American 100 14 BATO 2023-11-17
O:MRNS231117C00013000 OCASPS Call American 100 13 BATO 2023-11-17
O:MRNS231117C00012000 OCASPS Call American 100 12 BATO 2023-11-17
O:MRNS231117C00011000 OCASPS Call American 100 11 BATO 2023-11-17
O:MRNS231117C00010000 OCASPS Call American 100 10 BATO 2023-11-17
O:MRNS231117C00009000 OCASPS Call American 100 9 BATO 2023-11-17
O:MRNS231117C00008000 OCASPS Call American 100 8 BATO 2023-11-17
O:MRNS231117C00007000 OCASPS Call American 100 7 BATO 2023-11-17
O:MRNS231117C00006000 OCASPS Call American 100 6 BATO 2023-11-17
O:MRNS231117C00005000 OCASPS Call American 100 5 BATO 2023-11-17
O:MRNS231117C00004000 OCASPS Call American 100 4 BATO 2023-11-17
O:MRNS231117C00003000 OCASPS Call American 100 3 BATO 2023-11-17
O:MRNS231117C00002000 OCASPS Call American 100 2 BATO 2023-11-17
O:MRNS231117C00001000 OCASPS Call American 100 1 BATO 2023-11-17
O:MRNS231020C00016000 OCASPS Call American 100 16 BATO 2023-10-20
O:MRNS231020C00015000 OCASPS Call American 100 15 BATO 2023-10-20
O:MRNS231020C00014000 OCASPS Call American 100 14 BATO 2023-10-20
O:MRNS231020C00013000 OCASPS Call American 100 13 BATO 2023-10-20
O:MRNS231020C00012000 OCASPS Call American 100 12 BATO 2023-10-20
O:MRNS231020C00011000 OCASPS Call American 100 11 BATO 2023-10-20
O:MRNS231020C00010000 OCASPS Call American 100 10 BATO 2023-10-20
O:MRNS231020C00009000 OCASPS Call American 100 9 BATO 2023-10-20
O:MRNS231020C00008000 OCASPS Call American 100 8 BATO 2023-10-20
O:MRNS231020C00007000 OCASPS Call American 100 7 BATO 2023-10-20
O:MRNS231020C00006000 OCASPS Call American 100 6 BATO 2023-10-20
O:MRNS231020C00005000 OCASPS Call American 100 5 BATO 2023-10-20
O:MRNS231020C00004000 OCASPS Call American 100 4 BATO 2023-10-20
O:MRNS231020C00003000 OCASPS Call American 100 3 BATO 2023-10-20
O:MRNS231020C00002000 OCASPS Call American 100 2 BATO 2023-10-20
O:MRNS231020C00001000 OCASPS Call American 100 1 BATO 2023-10-20
O:MRNS231020P00020000 OPASPS Put American 100 20 BATO 2023-10-20
O:MRNS231020P00016000 OPASPS Put American 100 16 BATO 2023-10-20
O:MRNS231020P00015000 OPASPS Put American 100 15 BATO 2023-10-20
O:MRNS231020P00014000 OPASPS Put American 100 14 BATO 2023-10-20
O:MRNS231020P00013000 OPASPS Put American 100 13 BATO 2023-10-20
O:MRNS231020P00012000 OPASPS Put American 100 12 BATO 2023-10-20
O:MRNS231020P00011000 OPASPS Put American 100 11 BATO 2023-10-20
O:MRNS231020P00010000 OPASPS Put American 100 10 BATO 2023-10-20
O:MRNS231020P00009000 OPASPS Put American 100 9 BATO 2023-10-20
O:MRNS231020P00008000 OPASPS Put American 100 8 BATO 2023-10-20
O:MRNS231020P00007000 OPASPS Put American 100 7 BATO 2023-10-20
O:MRNS231020P00006000 OPASPS Put American 100 6 BATO 2023-10-20
O:MRNS231020P00005000 OPASPS Put American 100 5 BATO 2023-10-20
O:MRNS231020P00004000 OPASPS Put American 100 4 BATO 2023-10-20
O:MRNS231020P00003000 OPASPS Put American 100 3 BATO 2023-10-20
O:MRNS231020P00002000 OPASPS Put American 100 2 BATO 2023-10-20
O:MRNS231020P00001000 OPASPS Put American 100 1 BATO 2023-10-20
O:MRNS231020C00020000 OCASPS Call American 100 20 BATO 2023-10-20
O:MRNS230915P00003000 OPASPS Put American 100 3 BATO 2023-09-15
O:MRNS230915P00002000 OPASPS Put American 100 2 BATO 2023-09-15
O:MRNS230915C00019000 OCASPS Call American 100 19 BATO 2023-09-15
O:MRNS230915C00018000 OCASPS Call American 100 18 BATO 2023-09-15
O:MRNS230915C00017000 OCASPS Call American 100 17 BATO 2023-09-15
O:MRNS230915C00016000 OCASPS Call American 100 16 BATO 2023-09-15
O:MRNS230915C00015000 OCASPS Call American 100 15 BATO 2023-09-15
O:MRNS230915C00014000 OCASPS Call American 100 14 BATO 2023-09-15
O:MRNS230915C00013000 OCASPS Call American 100 13 BATO 2023-09-15
O:MRNS230915C00012000 OCASPS Call American 100 12 BATO 2023-09-15
O:MRNS230915C00011000 OCASPS Call American 100 11 BATO 2023-09-15
O:MRNS230915C00010000 OCASPS Call American 100 10 BATO 2023-09-15
O:MRNS230915C00009000 OCASPS Call American 100 9 BATO 2023-09-15
O:MRNS230915C00008000 OCASPS Call American 100 8 BATO 2023-09-15
O:MRNS230915C00007000 OCASPS Call American 100 7 BATO 2023-09-15
O:MRNS230915C00006000 OCASPS Call American 100 6 BATO 2023-09-15
O:MRNS230915C00005000 OCASPS Call American 100 5 BATO 2023-09-15
O:MRNS230915C00004000 OCASPS Call American 100 4 BATO 2023-09-15
O:MRNS230915C00003000 OCASPS Call American 100 3 BATO 2023-09-15
O:MRNS230915C00002000 OCASPS Call American 100 2 BATO 2023-09-15
O:MRNS230915P00019000 OPASPS Put American 100 19 BATO 2023-09-15
O:MRNS230915P00018000 OPASPS Put American 100 18 BATO 2023-09-15
O:MRNS230915P00017000 OPASPS Put American 100 17 BATO 2023-09-15
O:MRNS230915P00016000 OPASPS Put American 100 16 BATO 2023-09-15
O:MRNS230915P00015000 OPASPS Put American 100 15 BATO 2023-09-15
O:MRNS230915P00014000 OPASPS Put American 100 14 BATO 2023-09-15
O:MRNS230915P00013000 OPASPS Put American 100 13 BATO 2023-09-15
O:MRNS230915P00012000 OPASPS Put American 100 12 BATO 2023-09-15
O:MRNS230915P00011000 OPASPS Put American 100 11 BATO 2023-09-15
O:MRNS230915P00010000 OPASPS Put American 100 10 BATO 2023-09-15
O:MRNS230915P00009000 OPASPS Put American 100 9 BATO 2023-09-15
O:MRNS230915P00008000 OPASPS Put American 100 8 BATO 2023-09-15
O:MRNS230915P00007000 OPASPS Put American 100 7 BATO 2023-09-15
O:MRNS230915P00006000 OPASPS Put American 100 6 BATO 2023-09-15
O:MRNS230915P00005000 OPASPS Put American 100 5 BATO 2023-09-15
O:MRNS230915P00004000 OPASPS Put American 100 4 BATO 2023-09-15
O:MRNS230818P00002000 OPASPS Put American 100 2 BATO 2023-08-18
O:MRNS230818P00001000 OPASPS Put American 100 1 BATO 2023-08-18
O:MRNS230818C00002000 OCASPS Call American 100 2 BATO 2023-08-18
O:MRNS230818C00001000 OCASPS Call American 100 1 BATO 2023-08-18
O:MRNS230818P00020000 OPASPS Put American 100 20 BATO 2023-08-18
O:MRNS230818P00019000 OPASPS Put American 100 19 BATO 2023-08-18
O:MRNS230818P00018000 OPASPS Put American 100 18 BATO 2023-08-18
O:MRNS230818P00017000 OPASPS Put American 100 17 BATO 2023-08-18
O:MRNS230818P00016000 OPASPS Put American 100 16 BATO 2023-08-18
O:MRNS230818P00015000 OPASPS Put American 100 15 BATO 2023-08-18
O:MRNS230818P00014000 OPASPS Put American 100 14 BATO 2023-08-18
O:MRNS230818P00013000 OPASPS Put American 100 13 BATO 2023-08-18
O:MRNS230818P00012000 OPASPS Put American 100 12 BATO 2023-08-18
O:MRNS230818P00011000 OPASPS Put American 100 11 BATO 2023-08-18
O:MRNS230818P00010000 OPASPS Put American 100 10 BATO 2023-08-18
O:MRNS230818P00009000 OPASPS Put American 100 9 BATO 2023-08-18
O:MRNS230818P00008000 OPASPS Put American 100 8 BATO 2023-08-18
O:MRNS230818P00007000 OPASPS Put American 100 7 BATO 2023-08-18
O:MRNS230818P00006000 OPASPS Put American 100 6 BATO 2023-08-18
O:MRNS230818P00005000 OPASPS Put American 100 5 BATO 2023-08-18
O:MRNS230818P00004000 OPASPS Put American 100 4 BATO 2023-08-18
O:MRNS230818P00003000 OPASPS Put American 100 3 BATO 2023-08-18
O:MRNS230818C00020000 OCASPS Call American 100 20 BATO 2023-08-18
O:MRNS230818C00019000 OCASPS Call American 100 19 BATO 2023-08-18
O:MRNS230818C00018000 OCASPS Call American 100 18 BATO 2023-08-18
O:MRNS230818C00017000 OCASPS Call American 100 17 BATO 2023-08-18
O:MRNS230818C00016000 OCASPS Call American 100 16 BATO 2023-08-18
O:MRNS230818C00015000 OCASPS Call American 100 15 BATO 2023-08-18
O:MRNS230818C00014000 OCASPS Call American 100 14 BATO 2023-08-18
O:MRNS230818C00013000 OCASPS Call American 100 13 BATO 2023-08-18
O:MRNS230818C00012000 OCASPS Call American 100 12 BATO 2023-08-18
O:MRNS230818C00011000 OCASPS Call American 100 11 BATO 2023-08-18
O:MRNS230818C00010000 OCASPS Call American 100 10 BATO 2023-08-18
O:MRNS230818C00009000 OCASPS Call American 100 9 BATO 2023-08-18
O:MRNS230818C00008000 OCASPS Call American 100 8 BATO 2023-08-18
O:MRNS230818C00007000 OCASPS Call American 100 7 BATO 2023-08-18
O:MRNS230818C00006000 OCASPS Call American 100 6 BATO 2023-08-18
O:MRNS230818C00005000 OCASPS Call American 100 5 BATO 2023-08-18
O:MRNS230818C00004000 OCASPS Call American 100 4 BATO 2023-08-18
O:MRNS230818C00003000 OCASPS Call American 100 3 BATO 2023-08-18
News Stream
News News
Monday, in an interim analysis of Marinus Pharmaceuticals Inc’s (NASDAQ:MRNS) phase 3 RAISE trial, evaluating intravenous (IV) ganaxolone as a treatment for refractory status epilepticus (RSE), failed to meet pre-defined “stopping criteria.” Marinus has completed RAISE enrollment at approximately 100 patients, with topline results expected in the summer of 2024. The company said the future development of IV ganaxolone in refractory status epilepticus will be assessed following a review of the final RAISE study results. An independent Data Monitoring Committee (DMC) recommended continuing the study. Cantor Fitzgerald said it shifted focus to oral ganaxolone (O-GNX), which is progressing in the global Phase 3 TrustTSC study for tuberous ...Full story available on Benzinga.com
Benzinga • 4w ago
Analyst Analyst Ratings
Throughout the last three months, 4 analysts have evaluated Marinus Pharma (NASDAQ:MRNS), offering a diverse set of opinions from bullish to bearish. The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 1 1 0 0 Last 30D 1 0 0 0 0 1M Ago 1 1 1 0 0 2M Ago 0 0 0 0 0 3M Ago 0 0 0 0 0 Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $21.75, with a high estimate of $27.00 and a low estimate of $9.00. Observing a 141.67% increase, the current average has risen from the previous average price target of $9.00. Understanding Analyst Ratings: A Comprehensive Breakdown The standing of Marinus Pharma among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Douglas Tsao HC Wainwright & Co. Maintains Buy $27.00 - Jay Olson Oppenheimer Maintains Perform $9.00 $9.00 Brian Abrahams RBC Capital Maintains Outperform $24.00 - Douglas Tsao HC Wainwright & Co. Maintains Buy $27.00 - Key Insights: Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Marinus Pharma. This insight gives a snapshot of analysts' perspectives on the current state of the company. Rating: Offering ...Full story available on Benzinga.com
Benzinga • 1mo ago
stocks Analyst Ratings
Throughout the last three months, 4 analysts have evaluated Marinus Pharma (NASDAQ:MRNS), offering a diverse set of opinions from bullish to bearish. The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 1 1 0 0 Last 30D 1 0 0 0 0 1M Ago 1 1 1 0 0 2M Ago 0 0 0 0 0 3M Ago 0 0 0 0 0 Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $21.75, with a high estimate of $27.00 and a low estimate of $9.00. Observing a 141.67% increase, the current average has risen from the previous average price target of $9.00. Understanding Analyst Ratings: A Comprehensive Breakdown The standing of Marinus Pharma among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Douglas Tsao HC Wainwright & Co. Maintains Buy $27.00 - Jay Olson Oppenheimer Maintains Perform $9.00 $9.00 Brian Abrahams RBC Capital Maintains Outperform $24.00 - Douglas Tsao HC Wainwright & Co. Maintains Buy $27.00 - Key Insights: Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Marinus Pharma. This insight gives a snapshot of analysts' perspectives on the current state of the company. Rating: Offering ...Full story available on Benzinga.com
Benzinga • 1mo ago
News News
Investors need to pay close attention to Marinus (MRNS) stock based on the movements in the options market lately.
Zacks Investment Research • 1mo ago
News News
Marinus Pharmaceuticals (MRNS) delivered earnings and revenue surprises of -15.63% and 7.58%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Zacks Investment Research • 2mo ago
Analyst Analyst Ratings
Over the past 3 months, 5 analysts have published their opinion on Marinus Pharma (NASDAQ:MRNS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 2 0 0 0 Last 30D 1 0 0 0 0 1M Ago 1 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 1 2 0 0 0 According to 5 analyst offering 12-month price targets in the last 3 months, Marinus Pharma has ...Full story available on Benzinga.com
Benzinga • 5mo ago
News News
The average of price targets set by Wall Street analysts indicates a potential upside of 183.3% in Marinus Pharmaceuticals (MRNS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Zacks Investment Research • 7mo ago
Analyst Analyst Ratings
Within the last quarter, Marinus Pharma (NASDAQ:MRNS) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 4 4 1 0 0 Last 30D 1 1 0 0 0 1M Ago 0 0 0 0 0 2M Ago 3 2 1 0 0 3M Ago 0 1 0 0 0 In the last 3 months, 9 analysts have offered 12-month price targets for Marinus Pharma. The company has an average price target of $22.44 with a high of $32.00 and a low of $13.00. Below is a summary of how these 9 analysts rated Marinus Pharma over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock ...Full story available on Benzinga.com
Benzinga • 7mo ago
News News
Marinus Pharmaceuticals (MRNS) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks Investment Research • 7mo ago
Analyst Analyst Ratings
Over the past 3 months, 5 analysts have published their opinion on Marinus Pharma (NASDAQ:MRNS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3 1 0 0 Last 30D 0 1 1 0 0 1M Ago 0 0 0 0 0 2M Ago 1 1 0 0 0 3M Ago 0 1 0 0 0 In the last 3 months, 5 analysts have offered 12-month price targets for Marinus Pharma. The company has an average price target of $21.4 with a high of $28.00 and a low of $14.00. Below is a summary of how these 5 analysts rated Marinus ...Full story available on Benzinga.com
Benzinga • 9mo ago
See All

Contactez-nous dès aujourd'hui pour découvrir comment notre solution peut vous aider à tirer parti de la puissance des données.

CONTACTER UN EXPERT